Repetition of Prediabetes Enhances the Risk of Developing Diabetes

Table 6

Comorbidities of the excluded subjects.

(1) Anemia		Hb (g/dL)	FPG (mg/dL)	HbA1c (%)	PD3	DM
Iron deficiency (M)	12	11.2-13.8	83-105	4.7-5.9	3	2
Iron deficiency (F)	71	9.7-11.3	70-122	4.4-6.1	8	11
Hemolytic (M)	1	12.1-13.3	103-118	5.6-5.8	1	0
Renal (M)	1	10.9-12.0	85-99	5.6-5.8	0	0
(2) Others		Medication	FPG (mg/dL)	HbA1c (%)	PD3	DM
SLE (F)	2	PSL 5 mg	92-98	5.5-5.8	1	1
IgA retinopathy (F)	1	PSL	102-113	5.9-6.1	1	0
HES (M)	1	PSL 10 mg	96-101	5.1-5.2	0	0
Pancreatectomy (F)	1		92-109	5.9-6.1	1	1

Dose unknown. Hb: hemoglobin; FPG: fasting plasma glucose; PD3: subclassification of prediabetes in this study; DM: diabetes mellitus; (M): male; (F): female; SLE: systemic lupus erythematosus; HES: hypereosinophilic syndrome; PSL: prednisolone. Values of Hb, FPG, and HbA1c imply the lowest datum (average of the lowest data in the case of multiple) to the highest datum (average of the highest data in the case of multiple) during the entry period.